Kazuhiko Matsumoto Selected Research

Kazuhiko Matsumoto Research Topics

Disease

8	Neoplasms (Cancer) 12/2017 - 03/2003
7	Melanoma (Melanoma, Malignant) 12/2008 - 09/2002
3	Infections 01/2022 - 01/2018
3	Hyperthermia 09/2005 - 03/2003
2	Inflammation (Inflammations) 01/2022 - 09/2002
2	Virus Diseases (Viral Diseases) 01/2020 - 01/2018
2	Shock 10/2016 - 11/2015
2	Hypersensitivity (Allergy) 09/2004 - 02/2004
1	Cytokine Release Syndrome 01/2023
1	COVID-19 01/2023
1	Disease Progression 01/2023
1	Conversion Disorder (Astasia Abasia) 05/2022
1	Skin Diseases (Skin Disease) 02/2022
1	Mycosis Fungoides 02/2022
1	Hypohidrosis 04/2021
1	Influenza in Birds (Avian Flu) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 12/2019
1	Acanthosis Nigricans 07/2014
1	Gout 12/2011
1	Massive Hepatic Necrosis 12/2011
1	Glioma (Gliomas) 12/2008
1	Hand-Foot Syndrome 10/2008
1	Hemorrhage 10/2008
1	Erythema 10/2008
1	Edema (Dropsy) 10/2008
1	Experimental Melanoma 09/2005
1	Lymphoma (Lymphomas) 07/2005
1	Hyperplasia 09/2004
1	Breast Neoplasms (Breast Cancer) 06/2004
1	Blister (Bulla) 08/2003
1	Drug Eruptions (Drug Eruption) 04/2003
1	Asthma (Bronchial Asthma) 09/2002

Drug/Important Bio-Agent (IBA)

4	Liposomes (Liposome)IBA 12/2008 - 09/2002
3	CytokinesIBA 01/2023 - 09/2002
3	Interferon-betaIBA 12/2008 - 08/2003
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2017
2	Hemagglutinins (Hemagglutinin)IBA 01/2020 - 01/2018
2	Therapeutic UsesIBA 09/2005 - 07/2005
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2004 - 03/2003
1	InterferonsIBA 01/2023
1	niobium pentoxideIBA 05/2022
1	Ficusin (Psoralen)IBA 02/2022
1	Methoxsalen (Oxsoralen)FDA Link 02/2022
1	C-Reactive ProteinIBA 01/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022
1	Carbonic Anhydrase IIIBA 04/2021
1	Neuraminidase (Sialidase)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	GraphiteIBA 12/2019
1	Polysaccharides (Glycans)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2018
1	VaccinesIBA 01/2018
1	Peptides (Polypeptides)IBA 12/2017
1	Cathepsin EIBA 12/2017
1	OxidesIBA 10/2016
1	acetonitrileIBA 11/2015
1	Growth Hormone (Somatotropin)IBA 07/2014
1	BenzbromaroneIBA 12/2011
1	Cytochrome P-450 CYP2C9IBA 12/2011
1	Proteins (Proteins, Gene)FDA Link 12/2008
1	Histocompatibility Antigens Class IIIBA 12/2008
1	Phosphotransferases (Kinase)IBA 10/2008
1	Imatinib Mesylate (Gleevec)FDA Link 10/2008
1	Sorafenib (BAY 43-9006)FDA Link 10/2008
1	Sunitinib (Sutent)FDA Link 10/2008
1	Docetaxel (Taxotere)FDA Link 10/2008
1	Prostate-Specific Antigen (Semenogelase)IBA 04/2007
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2005
1	Ferrosoferric Oxide (Magnetite)FDA Link 09/2005
1	Analgesics (Analgesic Drugs)IBA 06/2004
1	Buprenorphine (Subutex)FDA LinkGeneric 06/2004
1	Carbamazepine (Tegretol)FDA LinkGeneric 02/2004
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2003
1	coproporphyrin IIIIBA 12/2003
1	Phosphates (Orthophosphate)IBA 08/2003
1	Dacarbazine (DIC)FDA LinkGeneric 08/2003
1	Ephedrine FDA LinkGeneric 04/2003
1	Pseudoephedrine FDA LinkGeneric 04/2003
1	Interleukin-2 (IL2)IBA 03/2003
1	Messenger RNA (mRNA)IBA 09/2002
1	OvalbuminIBA 09/2002
1	AerosolsIBA 09/2002
1	suplatast tosilateIBA 09/2002
1	aluminum sulfate (alum)IBA 09/2002
1	beta-Galactosidase (Lactaid)IBA 09/2002

Therapy/Procedure

6	Therapeutics 02/2022 - 07/2005
3	Immunotherapy 09/2005 - 03/2003
2	Photochemotherapy (Photodynamic Therapy) 02/2022 - 12/2003
2	Drug Therapy (Chemotherapy) 10/2008 - 07/2006
1	Oral Administration 02/2022
1	Intralesional Injections 07/2008
1	Induced Hyperthermia (Thermotherapy) 09/2005
1	Aftercare (After-Treatment) 08/2003
1	Transplantation 09/2002